IRELAND > USA based animal health group Phibro is set to create 150 jobs in Sligo, Ireland

Phibro logo Phibro, an animal health and mineral nutrition company, is set to create 150 jobs in Sligo, Ireland over the next five years. Phibro is headquartered in the US and it plans to establish a biotech facility producing a range of animal health vaccines at the IDA Business Park in Finisklin, Sligo, Ireland. Initially set to focus on producing Phibro’s vaccines More …

ITALY > USA based Arthrex is set to open a new office in North Naples

Arthrex logo US based Arthrex is expanding into Italy by setting up an office tower in North Naples. The first phase of construction includes the elevator shafts and stair towers for creating the company’s new event and administrative building in Creekside Commerce Park off Immokalee Road. According to Lisa Gardiner, a spokeswoman for Arthrex,: “Activities will continue to increase over the coming months. The More …

CANADA > USA based Peloton expands to Europe and Canada

Peloton logo New York based Technology Company that has revolutionized the fitness industry; Peloton is set to embark on global expansion with expansion in Europe and Canada.  Peloton created the category forming indoor cycling bike and the recently announced Peloton Tread and it will expand into the Canadian and European market by selling direct-to-consumer through its website, www.onepeloton.com, as well as owned retail More …

ISRAEL > USA based International Flavors & Fragrances Inc. is set to acquire Israel based Frutarom for $7.1 billion

IFF logo   International Flavors & Fragrances Inc.(IFF) and Frutarom have entered into a definite agreement under which IFF will acquire Frutarom in a cash and stock transaction for approximately $7.1 billion including the assumption of Frutarom’s net debt. Unanimously approved by the Board of Directors of both companies, Frutarom’s shareholder will receive $71.19 in cash and 0.249 of a share of More …

COSTA RICA > USA based Advant Medical expands into Costa Rica

Advant logo A global leader in medical device contract services and manufacturing solutions, Advant Medical is set to significantly invest for its expansion into Costa Rica creating 30 new jobs Advant has heavily invested in the 13,000 square foot facility with a 2,200 square foot, Class 8, cleanroom with capacity to manufacture Class I, II, III medical devices equipped with state of More …

NETHERLANDS > USA based ValGenesis expands its operations in Europe by establishing subsidiary ValGenesis EMEA in The Netherlands

Valgenesis logo The market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), ValGenesis, Inc., has announced the opening of its new subsidiary in the Netherlands. The subsidiary will assist ValGenesis’s expansion in European market along with ground sales and customer support for current clients and prospective clients in Europe. According to Mr. Robert van der Laan, Managing Director of ValGenesis EMEA: “The European More …

BELGIUM > Atlas Biomed has successfully launched in ten European countries including Belgium, Denmark, Finland, Republic of Ireland, Italy, Luxembourg, Slovenia, Spain, Sweden and the Netherlands

Atlas biomed logo Just after six months of launching in the UK, Atlas Biomed, the personalized health tech company launches in ten other European countries. Atlas Biomed offers DNA and microbiome tests directly to its customers and the expansion is as a result of strong sales in the UK. Owing its growth to health- conscious consumers and booming global genomics market, Atlas has More …

INDIA > Sweden based Medicover expands in the healthcare market in India

logo_medicover Medicover is set to acquire Medicover Fertility India and own 22% of Sahrudaya Healthcare Private limited “Maxcure” for approximately EUR 21 million($24.9 million). Fully funded by the principal shareholder but managed by Medicover, Medicover Fertility India was established in 2016. Medicover purchased this for $7.4 million which matches the original investment cost. Mediocover India had a revenue of EUR 0.3 More …